Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.70 --0 (-0%)
Previous Close $284.70    52 Week High $139.79 
Open $284.70    52 Week Low $82.07 
Day High $284.70    P/E 662.09 
Day Low $284.70    EPS $0.43 
Volume 921